ZURICH/BERLIN, Oct 12 (Reuters) - The Swiss blue-chip SMI was seen opening 0.9 percent higher at 8,718 points on Friday, according to premarket indications by bank Julius Baer .
Here are some of the main factors that may affect Swiss stocks:
Swiss Transport Minister Doris Leuthard played down a mid-October deadline from the European Commission to strike a deal on a new treaty cementing ties with Switzerland’s biggest trading partner.
Abbvie said on Thursday it settled all patent disputes with Novartis, granting it a non-exclusive license to manufacture and sell a copycat version of blockbuster drug, Humira.
* BB Biotech on Thursday reported a nine-month profit of 172 million francs compared with 843 million francs a year ago.
* Copper producer Atalaya Mining , which is backed by Swiss trading giant Trafigura, is looking for a buyer, two banking sources said on Thursday.
* CPH Chemie und Papier Holding said it expected its full-year net result to likely be more than double that of 2017.
* Adecco Group said it had appointed Gordana Landen its chief human resources officer.
No economic data due.
Reporting by Zurich newsroom and Berlin Speed Desk